NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where The Clorox Company (NYSE:CLX) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Texas Instruments Incorporated (NASDAQ:TXN) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where NNN REIT, Inc. (NYSE:NNN) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
Key Highlights – expected completion in YR 2025: OraTech Pharmaceuticals Inc. - A new joint venture focused on oral insulin development, with planned U.S....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the second quart...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Realty Income Corporation (NYSE:O) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Verizon Communications Inc. (NYSE:VZ) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many conservative […]
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed") (www.oramed.com), a clinical-stage pharmaceutical company focused on the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the first quarte...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Altria Group, Inc. (NYSE:MO) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies. Many […]
We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where The Procter & Gamble Company (NYSE:PG) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a […]
We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy. […]
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the fourth quart...
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...
/PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has...
We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where The Coca-Cola Company (NYSE:KO) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive […]
We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where Cisco Systems, Inc. (NASDAQ:CSCO) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive […]
In the first quarter, the AI-powered voice solutions provider continued to post strong revenue growth, but its sizable losses also continued.
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ applications, scaling up of manufacturing capabilities, and commercial preparations underway
Mentions: DRTS
New Standalone Company, OraTech Pharmaceuticals Inc., to Focus on Oral Drug Delivery with Strategic Investment and Advanced Manufacturing Capabilities Oramed...
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral...
Mentions: SCLX
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on...
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving...
Mentions: SCLX
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex")...
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) announced today that it has signed a non-binding term sheet with Hefei...
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract...